Building strategic engagement with a changing NHS We invited strategic UK market access and commercialisation teams to join us and our guest speakers for our NHS Transformation Symposium on Tuesday...
Read More
In the second episode of our Global Whispers webinar series, we explored market access for digital therapeutics. Clare Foy (Global Market Access Director – Mtech Access) spoke to Shefali Shah...
Read More
What does it take to bring a cannabinoid pharmaceutical to market? On Tuesday 23rd May Clare Foy (Global Market Access Director – Mtech Access) was joined by Michael Sassano (CEO...
Read More
What are surrogate endpoints and how can they support the accelerated approval of new medicines? Where and how are surrogate endpoints being used? In which disease areas and markets can...
Read More
How will changes to the structure of primary care impact decision making? How is the relationship between Integrated Care Boards (ICBs) and primary care stakeholders evolving? How will funding flows...
Read More
Heather Wellam (Senior Consultant – Market Access) explains the cost-effectiveness analysis process in Japan, answering FAQs and exploring challenges and opportunities.
Is data the key to transforming healthcare systems and patient care? What are the top priorities for digital transformation leaders in the NHS? How can Pharma and Medtech companies partner...
Read More
Will NHS leaders, as part of an Integrated Care System (ICS), make conscious decisions to drive economic and social change? What social and economic value do ICSs offer the wider...
Read More
Working with a dedicated market access and health economics and outcomes research (HEOR) consultancy offers significant added value to Pharma and Medical Device companies and can give you the confidence...
Read More
Elizabeth Thurgar tells us about her ISPOR poster reviewing fast-track appraisals at NICE and the evolution of cost comparison
